Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Archer-Daniels-Midland Co ha un obiettivo di prezzo di consenso pari a $68.22, stabilito in base alle ultime valutazioni degli analisti di 18. Le ultime 3 valutazioni degli analisti sono state rilasciate da JP Morgan, Morgan Stanley y UBS il agosto 20, 2025, agosto 12, 2025 y agosto 11, 2025. Con un obiettivo di prezzo medio di $62.67 tra le JP Morgan, Morgan Stanley y UBS, c'è un implicito 2.99% upside per Archer-Daniels-Midland Co da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
08/20/2025 | 0.25% | JP Morgan | $48 → $61 | Assumes | Neutral → Neutral | |||
08/12/2025 | -6.33% | Morgan Stanley | $47 → $57 | Maintains | Equal-Weight | |||
08/11/2025 | 15.04% | UBS | $60 → $70 | Maintains | Buy | |||
08/06/2025 | 0.25% | Barclays | $50 → $61 | Upgrade | Underweight → Equal-Weight | |||
07/02/2025 | -17.83% | Barclays | $48 → $50 | Maintains | Underweight | |||
05/19/2025 | -1.4% | UBS | $55 → $60 | Upgrade | Neutral → Buy | |||
05/08/2025 | -26.05% | B of A Securities | $47 → $45 | Downgrade | Neutral → Underperform | |||
04/15/2025 | -22.76% | B of A Securities | $48 → $47 | Upgrade | Underperform → Neutral | |||
04/15/2025 | -19.47% | Citigroup | $51 → $49 | Maintains | Neutral | |||
03/24/2025 | -9.61% | UBS | $64 → $55 | Maintains | Neutral | |||
02/24/2025 | -21.12% | Barclays | $50 → $48 | Maintains | Underweight | |||
02/11/2025 | -22.76% | Morgan Stanley | $52 → $47 | Maintains | Equal-Weight | |||
02/11/2025 | -21.12% | B of A Securities | $54 → $48 | Maintains | Underperform | |||
02/05/2025 | -19.47% | BMO Capital | $51 → $49 | Maintains | Market Perform | |||
02/04/2025 | -16.19% | Citigroup | $53 → $51 | Maintains | Neutral | |||
01/21/2025 | -17.83% | Barclays | $56 → $50 | Maintains | Underweight | |||
01/14/2025 | -11.26% | B of A Securities | $63 → $54 | Downgrade | Neutral → Underperform | |||
01/08/2025 | -12.9% | Citigroup | $55 → $53 | Maintains | Neutral | |||
12/04/2024 | -9.61% | Citigroup | $51 → $55 | Maintains | Neutral | |||
12/04/2024 | -16.19% | BMO Capital | $55 → $51 | Maintains | Market Perform | |||
12/04/2024 | -7.97% | Barclays | $60 → $56 | Maintains | Underweight | |||
11/12/2024 | -14.54% | Morgan Stanley | $57 → $52 | Maintains | Equal-Weight | |||
09/09/2024 | 5.18% | UBS | $60 → $64 | Maintains | Neutral | |||
07/31/2024 | 8.46% | JP Morgan | $65 → $66 | Maintains | Neutral | |||
07/15/2024 | 3.53% | Citigroup | $64 → $63 | Maintains | Neutral | |||
04/03/2024 | 5.18% | Citigroup | $63 → $64 | Maintains | Neutral | |||
03/14/2024 | 21.61% | B of A Securities | $85 → $74 | Maintains | Neutral | |||
03/13/2024 | -1.4% | BMO Capital | $66 → $60 | Maintains | Market Perform | |||
03/13/2024 | 6.82% | Jefferies | $70 → $65 | Maintains | Hold | |||
02/01/2024 | -6.33% | Citigroup | → $57 | Initiates | → Neutral | |||
01/26/2024 | -16.19% | UBS | $104 → $51 | Downgrade | Buy → Neutral | |||
01/23/2024 | 10.11% | Goldman Sachs | $90 → $67 | Maintains | Neutral | |||
01/22/2024 | -1.4% | Barclays | $95 → $60 | Downgrade | Overweight → Underweight | |||
01/22/2024 | -7.97% | Stifel | $116 → $56 | Downgrade | Buy → Hold | |||
01/22/2024 | 8.46% | Roth MKM | $98 → $66 | Downgrade | Buy → Neutral | |||
01/22/2024 | 8.46% | BMO Capital | $80 → $66 | Maintains | Market Perform | |||
01/22/2024 | 10.11% | Goldman Sachs | $90 → $67 | Downgrade | Buy → Neutral | |||
01/22/2024 | 0.25% | Baird | $96 → $61 | Downgrade | Outperform → Neutral | |||
12/20/2023 | 70.91% | UBS | $115 → $104 | Maintains | Buy | |||
12/18/2023 | 31.47% | BMO Capital | → $80 | Downgrade | Outperform → Market Perform | |||
10/30/2023 | 24.9% | Morgan Stanley | $87 → $76 | Maintains | Equal-Weight | |||
10/25/2023 | 23.25% | JP Morgan | $77 → $75 | Maintains | Neutral | |||
10/25/2023 | 23.25% | Stephens & Co. | $80 → $75 | Maintains | Equal-Weight | |||
10/19/2023 | 26.54% | JP Morgan | $85 → $77 | Maintains | Neutral | |||
08/01/2023 | 56.12% | Argus Research | $91 → $95 | Maintains | Buy | |||
08/01/2023 | 42.97% | Morgan Stanley | $83 → $87 | Maintains | Equal-Weight | |||
07/31/2023 | 42.97% | Morgan Stanley | $83 → $87 | Maintains | Equal-Weight | |||
07/17/2023 | 36.4% | Morgan Stanley | $83 → $83 | Reiterates | Equal-Weight → Equal-Weight | |||
06/22/2023 | 51.19% | Roth MKM | → $92 | Initiates | → Buy | |||
06/01/2023 | 56.12% | Barclays | $99 → $95 | Maintains | Overweight | |||
04/27/2023 | 36.4% | Morgan Stanley | $85 → $83 | Maintains | Equal-Weight | |||
04/26/2023 | 47.9% | Baird | $98 → $90 | Maintains | Outperform | |||
04/26/2023 | 62.7% | Barclays | $105 → $99 | Maintains | Overweight | |||
04/14/2023 | 64.34% | BMO Capital | → $100 | Reinstates | → Outperform | |||
04/13/2023 | 64.34% | BMO Capital | → $100 | Reinstates | → Outperform | |||
04/13/2023 | 39.69% | Morgan Stanley | $94 → $85 | Maintains | Equal-Weight | |||
04/12/2023 | 39.69% | JP Morgan | $87 → $85 | Maintains | Neutral | |||
01/30/2023 | 42.97% | JP Morgan | $88 → $87 | Maintains | Neutral | |||
01/19/2023 | 44.62% | JP Morgan | $84 → $88 | Maintains | Neutral | |||
01/03/2023 | 90.63% | Stifel | $114 → $116 | Maintains | Buy | |||
12/14/2022 | 88.99% | UBS | → $115 | Initiates | → Buy | |||
10/26/2022 | 64.34% | BMO Capital | $95 → $100 | Maintains | Market Perform | |||
10/26/2022 | 61.05% | Baird | $94 → $98 | Maintains | Outperform | |||
10/25/2022 | 87.35% | Stifel | $111 → $114 | Maintains | Buy | |||
10/24/2022 | 64.34% | B of A Securities | $104 → $100 | Maintains | Neutral |
El último precio objetivo de Archer-Daniels-Midland (NYSE:ADM) fue comunicado por JP Morgan el agosto 20, 2025. La firma de analistas fijó un precio objetivo para $61.00 que espera ADM a rise dentro de 12 meses (un posible 0.25% upside). 22 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Archer-Daniels-Midland (NYSE:ADM) fue proporcionada por JP Morgan, y Archer-Daniels-Midland su neutral calificación.
La última revisión al alza de Archer-Daniels-Midland Co se produjo en agosto 6, 2025, cuando Barclays elevó su precio objetivo a $61. Barclays anteriormente tenía an underweight para Archer-Daniels-Midland Co.
La última revisión a la baja de Archer-Daniels-Midland Co se produjo en mayo 8, 2025, cuando B of A Securities cambió su precio objetivo de $47 a $45 para Archer-Daniels-Midland Co.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Archer-Daniels-Midland, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Archer-Daniels-Midland se registró el agosto 20, 2025, por lo que la próxima calificación estará disponible en torno al agosto 20, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Archer-Daniels-Midland (ADM) fue un con un precio objetivo de $48.00 a $61.00. El precio actual al que cotiza Archer-Daniels-Midland (ADM) es de $60.85, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.